These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53. The effect of penicillamine on the laboratory parameters in rheumatoid arthritis. Jaffe IA Arthritis Rheum; 1965 Dec; 8(6):1064-79. PubMed ID: 5884817 [No Abstract] [Full Text] [Related]
54. Balancing effectiveness and toxicity of levamisole in the treatment of rheumatoid arthritis. Runge LA; Rynes RI Clin Exp Rheumatol; 1983; 1(2):125-31. PubMed ID: 6398156 [TBL] [Abstract][Full Text] [Related]
55. Penicillamine in the treatment of rheumatoid arthritis. Huskisson EC; Hart FD Ann Rheum Dis; 1972 Sep; 31(5):402-4. PubMed ID: 5071635 [No Abstract] [Full Text] [Related]
56. Determination of T lymphocyte subpopulations by monoclonal antibodies in rheumatoid arthritis. Influence of immunomodulating agents. Veys EM; Hermanns P; Goldstein G; Kung P; Schindler J; Van Wauwe J Int J Immunopharmacol; 1981; 3(3):313-9. PubMed ID: 6457008 [TBL] [Abstract][Full Text] [Related]
57. [Long term treatment of rheumatoid arthritis. Experiences with D-penicillamine in comparison with gold and immunosuppressive drugs (author's transl)]. Warnatz H; Scheiffarth F; Gutmann W Med Klin; 1975 Sep; 70(38):1509-15. PubMed ID: 810648 [TBL] [Abstract][Full Text] [Related]
58. [Chlorbutin, azathioprine, D-penicillamine and dekaris (levamisole) in the treatment of rheumatoid arthritis. Comparative analysis of their effect on the indices of disease activity and progression]. Krel' AA; Kanevskaia MZ; Rashchupkina ZP; Bolotin EV; Chichasova NV Ter Arkh; 1982; 54(6):82-92. PubMed ID: 7112429 [No Abstract] [Full Text] [Related]